Shares of Indian Drugmaker Strides Fall by 5% After US FDA Says Firm Tried to Destroy Quality Records Before Inspection

The destruction of quality-control paperwork and a lack of adequate documentation that its medicines are safe 'raise questions about the effectiveness' of Strides's quality unit, the FDA wrote in its letter.

from Top Business News- News18.com https://ift.tt/2O1hGxw

• Tweet
• Share
• Share
• Share
• Share